Maxygen Holdings Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy (NCT00501332) | Maxygen Holdings Ltd. | 2007-07-01 |
Track Maxygen Holdings Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.